A study using breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts suggested that GPER is involved in regulating fatty acid synthase (FASN) expression and activity in cancer cells and cancer-associated fibroblasts, which contributes to cancer progression [112]. The gene discussed is FASN; the disease is breast cancer.